US Patent Issued to PROVINCIAL HEALTH SERVICES AUTHORITY, THE UNIVERSITY OF BRITISH COLUMBIA on Nov. 18 for "Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancer" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,272, issued on Nov. 18, was assigned to PROVINCIAL HEALTH SERVICES AUTHORITY (Vancouver, Canada) and THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada).

"Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancer" was invented by Kuo-Shyan Lin (Richmond, Canada), Francois Benard (Vancouver, Canada), Hsiou-Ting Kuo (Sherbrooke, Canada), Helen Merkens (Burnaby, Canada) and Zhengxing Zhang (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to compounds of Formula I. R1a, R1b and R1c is -CO2H, -SO2H, -SO3H, -SO4H, -PO2H, -PO3H or -PO4H. R2 is a linker, e.g. buty...